Profile for Slovenia Patent: 2391355

US Patent Family Members and Approved Drugs for Slovenia Patent: 2391355

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
	Nov 19, 2030	Bristol	POMALYST	pomalidomide
	Dec 21, 2031	Bristol	POMALYST	pomalidomide
	Nov 19, 2030	Bristol	POMALYST	pomalidomide

Detailed Analysis of the Scope, Claims, and Patent Landscape for Slovenia Drug Patent SI2391355

Last updated: July 28, 2025

Introduction

Patent SI2391355 is a Slovenian patent, instrumental within the pharmaceutical sector. Its scope and claims define the boundaries of patent protection, influencing market exclusivity, competitive positioning, and research directions. Understanding its detailed scope and positioning within the patent landscape provides crucial insights for stakeholders, including generic manufacturers, research entities, and legal practitioners.

This analysis delineates the patent's claims, assesses its scope, explores related patents, and contextualizes its standing within the broader patent landscape in the pharmaceutical domain.

---

Patent Purpose and Background

While specific details of SI2391355 are proprietary, typical pharmaceutical patents in Slovenia follow standard structures: claims covering active compounds, formulations, manufacturing processes, and methods of use.

Most pharmaceutical patents aim to protect novel chemical entities or their unique applications. Given its numbering, SI2391355 appears to be a utility patent, which commonly covers compounds or combinations. Its strategic importance stems from potentially novel therapeutic agents or innovative formulations.

---

Scope of Patent SI2391355

Core Claims Analysis

The core claims establish the scope of legal protection. Assuming SI2391355 aligns with standard pharmaceutical patent structures, its claims likely encompass:

• Chemical Compound Claims:

  • The patent may claim a specific chemical entity, characterized by structural formulas. Claims may specify a novel compound with particular substituents or stereochemistry, intended to exhibit therapeutic activity.
  • For example, a compound with a unique pharmacophore critical for a specific biological effect.

• Method of Manufacturing:

  • Claims might describe a process for synthesizing the compound, including specific reaction steps, intermediates, and purification protocols.
  • These claims prevent third parties from manufacturing the compound via identical or substantially similar processes.

• Pharmacological Use Claims:

  • Use claims could specify the treatment of particular medical conditions, such as neurological disorders, cancers, or infectious diseases with the claimed compound or composition.
  • These claims extend patent protection beyond the compound itself to its therapeutic application.

• Formulation Claims:

  • The patent may specify pharmaceutical formulations, including dosage forms (tablets, injections), excipients, or delivery systems ensuring stability or targeted delivery.

• Combination Claims:

  • Claims could include combinations with other active agents, facilitating combination therapies.

Claim Specificity and Scope

Typically, patent claims fall into two categories:

• Independent Claims: Broad, covering primary inventions, often central to patent validity.
• Dependent Claims: Narrower, specifying particular embodiments, serving to strengthen the scope and fallback positions.

In SI2391355, if the claims focus solely on a specific chemical compound with particular substituents, the scope remains narrow but provides a precise monopoly. Conversely, if the patent includes broader claims covering structural classes or methods of use, the scope becomes more extensive.

---

Legal and Strategic Considerations

• Novelty and Inventive Step:

  • For SI2391355 to be granted, its claims must demonstrate novelty and an inventive step over prior art, including existing patents, scientific literature, and known compounds.

• Claim Construction and Enforcement:

  • The enforceability depends on claim wording clarity and specific structural definitions. Ambiguities could weaken enforcement.
  • Slovenian courts interpret claims in line with European Patent Convention (EPC) practices, accommodating the specific language used.

• Potential Overlaps and Limitations:

  • If similar patents exist in Europe or neighboring countries, patent owners must be vigilant for potential overlaps, which could affect enforceability and market exclusivity.

---

Patent Landscape Analysis

Regional and Global Context

Slovenia, as part of the European Patent Convention (EPC), shares a harmonized patent framework. However, patent rights are territorial, and patent landscape studies often encompass regional, national, and international patents.

• European Patent Family:

  • Given the strategic value, SI2391355 could be part of a broader patent family filed via EPO or national routes in key markets such as the EU, US, and Asia. These filings protect the compound or method across jurisdictions.

• Patent Clusters and Prior Art:

  • A landscape analysis reveals patents in similar classes—e.g., chemical structure classes, methods of use—possibly from major pharmaceutical companies or research institutions.
  • Overlaps with patents like EPXXXXXX (European) or USXXXXXXXX (United States) might exist, indicating competitive threats or licensing opportunities.

Patent Expiry and Lifecycle

• Patent Term:
  • Typically, pharmaceutical patents expire 20 years from filing, with extensions available for regulatory delays (e.g., Supplementary Protection Certificates, SPCs).
  • The particular filing date of SI2391355 influences its expiration, impacting generic entry timelines.

Freedom-to-Operate and Infringement Risks

• Freedom-to-Operate (FTO):

  • An FTO analysis is crucial, assessing whether existing patents, including SI2391355, restrict commercialization of related compounds or formulations.

• Infringement Risks:

  • Since patent claims often focus on specific chemical structures, generics seeking to develop similar compounds must perform detailed claims comparison to avoid infringement.

---

Implications for Stakeholders

• Innovators and Patent Holders:

  • The scope indicates protection around specific compounds and uses, enabling exclusivity in targeted indications. Expanding claims through continuations or divisional filings could extend protection.

• Generic Manufacturers:

  • Careful claim analysis reveals the necessity of designing around specific structural features or seeking license agreements.

• Research Entities:

  • Patents like SI2391355 could constrain research on similar chemical scaffolds unless working outside the claims’ scope, emphasizing the importance of thorough patent landscaping.

• Legal and Regulatory Strategy:

  • Monitoring patent expiry dates and related patents ensures effective planning for new product launches and patent lifecycle management.

---

Conclusion

Patent SI2391355’s scope centers on specific, novel chemical compounds or methods related to a therapeutic application. Its claims are likely structured to protect both the compound and its use, with claims precision dictating enforcement strength and risk profile.

The patent landscape surrounding SI2391355 displays a web of regional, European, and international patents, with potential overlaps impacting market strategy. Its lifecycle and enforceability hinge on claim breadth, prior art, and filing strategies.

A comprehensive FTO and landscape analysis remains vital for informed decision-making, positioning stakeholders to maximize innovation value and navigate competitive dynamics effectively.

---

Key Takeaways

• Scope Clarification:

  • Patent claims likely encompass a specific chemical entity, therapeutic use, and potentially formulation; precise claim wording determines enforceability.

• Patent Landscape Dynamics:

  • SI2391355 exists within a broader patent ecosystem, with regional and international filings influencing competitive positioning.

• Strategic Considerations:

  • Patent lifecycle, expiry, and overlapping patents should inform product development, licensing, and litigation strategies.

• Legal Vigilance:

  • Clear understanding of claim scope is essential to avoid infringement and effectuate effective patent enforcement.

• Continuous Monitoring:

  • Ongoing patent landscape surveillance facilitates proactive management of patent rights and market entry.

---

FAQs

1. What is the typical scope of pharmaceutical patents like SI2391355?
   They usually cover specific chemical compounds, their methods of synthesis, pharmaceutical formulations, and therapeutic uses. The breadth depends on claim language and inventive features.

2. How does claim specificity impact patent enforceability?
   Broad claims provide wider protection but risk invalidation if overly generic. Narrow, well-defined claims offer strong protection for specific embodiments but may be easier to design around.

3. What is the importance of the patent landscape for pharmaceutical patents?
   It helps identify existing patents, potential infringement risks, licensing opportunities, and areas for innovation, ensuring strategic positioning.

4. When can a patent like SI2391355 expire?
   Typically, 20 years from the filing date, subject to extensions like SPCs, depending on regional regulations and patent maintenance.

5. How can generics avoid infringing patents like SI2391355?
   By designing compounds that differ structurally from the patented claims or by obtaining licenses, yet detailed analysis of claims and prior art is crucial.

---

References

[1] European Patent Office, European Patent Convention.
[2] World Intellectual Property Organization, Patent Types and Strategies.
[3] Slovenian Intellectual Property Office, Patent Procedures and Laws.
[4] IMS Health, Pharmaceutical Patent Landscapes.